leisure time -WSS

leisure time

author：fashion 2025-10-01 18:44:40 - browse：86773

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： The United States must get value

hotspot

WSS

WuXi Biologics execs register to lobby as Congress comes for the company

The United States must get value

Health tech startups drop sharply from 2021 highs

How the Dana

Medicaid, Medicare dual

Oak Street deal isn't the answer to health care's woes

focus

leisure time

entertainment

Heart attack and stroke risk calculators need revising

ALS treatment from Biogen, Ionis fails in study

Drug repurposing or repositioning? The language matters

Novo Nordisk testing Wegovy against alcohol

After affirmative action ruling, medical educators look to 'holistic review'

Health tech startups drop sharply from 2021 highs

BioMarin wins approval for gene therapy to treat hemophilia A

Inequities make cancer less preventable for women: report

Tori Bowie and the unacceptable rates of Black maternal death

Sudafed saga points to U.S. issues with evaluating older drugs

entertainment

Menendez indictment could see pharma lose a key ally

Data show record exodus of life scientists from academia

What a koala virus tells us about the human genome

Shingles, which affected Dianne Feinstein, is on the rise

Researchers use wearables data and AI to predict preterm birth risk

FDA seeks to regulate lab

leisure time

hotspot

hotspot

Wikipedia